Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) represent a promising tool for new clinical concepts in supporting cellular therapy. Bone marrow (BM) was the first source reported to contain MSCs. However, for clinical use, BM may be detrimental due to the highly invasive donation procedure and the decline in MSC number and differentiation potential with increasing age. More recently, umbilical cord blood (UCB), attainable by a less invasive method, was introduced as an alternative source for MSCs. Another promising source is adipose tissue (AT). We compared MSCs derived from these sources regarding morphology, the success rate of isolating MSCs, colony frequency, expansion potential, multiple differentiation capacity, and immune phenotype. No significant differences concerning the morphology and immune phenotype of the MSCs derived from these sources were obvious. Differences could be observed concerning the success rate of isolating MSCs, which was 100% for BM and AT, but only 63% for UCB. The colony frequency was lowest in UCB, whereas it was highest in AT. However, UCB-MSCs could be cultured longest and showed the highest proliferation capacity, whereas BM-MSCs possessed the shortest culture period and the lowest proliferation capacity. Most strikingly, UCB-MSCs showed no adipogenic differentiation capacity, in contrast to BM- and AT-MSCs. Both UCB and AT are attractive alternatives to BM in isolating MSC: AT as it contains MSCs at the highest frequency and UCB as it seems to be expandable to higher numbers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As plating density can affect proliferation kinetics of MSCs [16, 23], cells from all tissue sources were grown for at least two passages under two seeding densities: 300 and 3000 cells/cm2.”
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Mesenchymal progenitor cells in human umbilical cord blood
Erices, A., Conget, P., & Minguell, J. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01986.x · Cited by 1,613
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W., et al. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.003 · Cited by 1,259
Stenderup, K. (2003) · Bone · doi:10.1016/j.bone.2003.07.005 · Cited by 1,206
Kögler, G., Sensken, S., Airey, J. A., Trapp, T., Müschen, M., Feldhahn, N., Liedtke, S., Sorg, R. V., Fischer, J., Rosenbaum, C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040440 · Cited by 1,029
Research works printed but not linked: 1
- 10.1210/endo.134.1.8275945 · doi:10.1210/endo.134.1.8275945 · Paper page
Cited by
Huang, G. T.-J., Gronthos, S., & Shi, S. (2009) · Journal of Dental Research · doi:10.1177/0022034509340867 · Cited by 1,871
“MSCs from BM, adipose tissue, and umbilical cord blood are morphologically and immunophenotypically similar, but not identical (Kern et al., 2006).”
BackgroundHass, R., Kasper, C., Böhm, S., & Jacobs, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-12 · Cited by 1,748
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine
Murphy, M. B., Moncivais, K., & Caplan, A. I. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.94 · Cited by 1,231
Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process
Wagner, W., Horn, P., Castoldi, M., Diehlmann, A., Bork, S., Saffrich, R., Benes, V., Blake, J., Pfister, S., Eckstein, V., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002213 · Cited by 1,129
“MSC isolated from different tissues have different functional properties including different long-term growth kinetics [30,33].”
BackgroundResultSchäffler, A., & Büchler, C. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0589 · Cited by 1,027
Liu, H., Wang, C., Li, C., Qin, Y., Wang, Z., Yang, F., Li, Z., & Wang, J. (2018) · RSC Advances · doi:10.1039/c7ra13510f · Cited by 915
Jo, C. H., Lee, Y. G., Shin, W. H., Kim, H., Chai, J. W., Jeong, E. C., Kim, J. E., Shim, H., Shin, J. S., Shin, I. S., et al. (2014) · STEM CELLS · doi:10.1002/stem.1634 · Cited by 911
Ding, D.-C., Shyu, W.-C., & Lin, S.-Z. (2011) · Cell Transplantation · doi:10.3727/096368910x · Cited by 894
Strioga, M., Viswanathan, S., Darinskas, A., Slaby, O., & Michalek, J. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0722 · Cited by 825
“Some studies have found that ASCs display pronounced adipogenic differentiation compared with BM-MSCs in vitro [149,154]; however; others have not reproduced those differences in the adipogenic differentiation capacity [112,145,146,155].”
InfluentialFrom basics to clinical: A comprehensive review on spinal cord injury
Silva, N. A., Sousa, N., Reis, R. L., & Salgado, A. J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.002 · Cited by 814
Concise Review: Wharton's Jelly-Derived Cells Are a Primitive Stromal Cell Population
Troyer, D. L., & Weiss, M. L. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0439 · Cited by 767
Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery
Yeo, R. W. Y., Lai, R. C., Zhang, B., Tan, S. S., Yin, Y., Teh, B. J., & Lim, S. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.001 · Cited by 746
“The ever expanding list of tissues for MSC isolation include adipose tissue [67,68], liver [70], muscle [71], amniotic fluid [72], placenta [73,74], umbilical cord blood [67], dental pulp [75,76], human ESC [78] and other sources [70,77].”
BackgroundJin, H., Bae, Y., Kim, M., Kwon, S.-J., Jeon, H., Choi, S., Kim, S., Yang, Y., Oh, W., & Chang, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917986 · Cited by 663
“[23] concluded that AT is suitable as it contains MSCs at the highest frequency and UCB as it seems to be expandable to higher numbers.”
InfluentialBiological functions of mesenchymal stem cells and clinical implications
Naji, A., Eitoku, M., Favier, B., Deschaseaux, F., Rouas-Freiss, N., & Suganuma, N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03125-1 · Cited by 624
Concise Review: Mesenchymal Stem Cells: From Roots to Boost
Andrzejewska, A., Lukomska, B., & Janowski, M. (2019) · Stem Cells · doi:10.1002/stem.3016 · Cited by 611
Isolation, cultivation, and characterization of human mesenchymal stem cells
Mushahary, D., Spittler, A., Kasper, C., Weber, V., & Charwat, V. (2018) · Cytometry Part A · doi:10.1002/cyto.a.23242 · Cited by 599
Meng, W., He, C., Hao, Y., Wang, L., Li, L., & Zhu, G. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1748758 · Cited by 592
“, 2007), umbilical cord blood (Kern et al., 2006), liver (G€ otherstr€ om et al.”
BackgroundInfluentialPeripheral nerve regeneration: Experimental strategies and future perspectives
Faroni, A., Mobasseri, S. A., Kingham, P. J., & Reid, A. J. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.010 · Cited by 592
Bioactive hydrogels for bone regeneration
Bai, X., Gao, M., Syed, S., Zhuang, J., Xu, X., & Zhang, X.-Q. (2018) · Bioactive Materials · doi:10.1016/j.bioactmat.2018.05.006 · Cited by 556
Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes
Banas, A., Teratani, T., Yamamoto, Y., Tokuhara, M., Takeshita, F., Quinn, G., Okochi, H., & Ochiya, T. (2007) · Hepatology · doi:10.1002/hep.21704 · Cited by 555
Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement
Ullah, M., Liu, D. D., & Thakor, A. S. (2019) · iScience · doi:10.1016/j.isci.2019.05.004 · Cited by 549
“Low-confluence MSCs expressed more proliferation-related genes, whereas highconfluence MSCs expressed more genes linked to activation (CXCL1, CXCL2, CXCL5, CXCL6, CXCL8, CXCL16), immune modulation (IL-1B, IL-6), migration, and regeneration (VEGFA, FGF9, PDFGD, A2M, MDK, WISP2, GDF15) (Kim et al., 2014).”
BackgroundExosomes for drug delivery—A novel application for the mesenchymal stem cell
Lai, R. C., Yeo, R. W. Y., Tan, K. H., & Lim, S. K. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.08.008 · Cited by 546
“, 2006), umbilical cord blood (Erices et al., 2003; Kern et al., 2006), dental pulp (Huang et al.”
BackgroundInfluentialKjærgaard, K., Dreyer, C. H., Ditzel, N., Andreasen, C. M., Chen, L., Sheikh, S. P., Overgaard, S., & Ding, M. (2016) · Stem Cells International · doi:10.1155/2016/3846971 · Cited by 524
Bieback, K., Hecker, A., Kocaömer, A., Lannert, H., Schallmoser, K., Strunk, D., & Klüter, H. (2009) · Stem Cells · doi:10.1002/stem.139 · Cited by 505
Self-citationWalter, M. N. M., Wright, K. T., Fuller, H. R., MacNeil, S., & Johnson, W. E. B. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.026 · Cited by 496
HEO, J. S., CHOI, Y., KIM, H.-S., & KIM, H. O. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2413 · Cited by 495
Lai, R. C., Tan, S. S., Teh, B. J., Sze, S. K., Arslan, F., de Kleijn, D. P., Choo, A., & Lim, S. K. (2012) · International Journal of Proteomics · doi:10.1155/2012/971907 · Cited by 485
Aging and Replicative Senescence Have Related Effects on Human Stem and Progenitor Cells
Wagner, W., Bork, S., Horn, P., Krunic, D., Walenda, T., Diehlmann, A., Benes, V., Blake, J., Huber, F.-X., Eckstein, V., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005846 · Cited by 477
“Thus, the total number of cumulative population doublings would be between 14 and 31 corresponding to a 10fold to 10-fold expansion as also described by others [12,18–20].”
BackgroundIsolation and Culture of Epithelial Progenitors and Mesenchymal Stem Cells from Human Endometrium1
Gargett, C. E., Schwab, K. E., Zillwood, R. M., Nguyen, H. P. T., & Wu, D. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.075226 · Cited by 475
“Similarly, large endometrial stromal CFU demonstrate substantial proliferative capacity (30 PDs), greater than most human bone marrow, dental pulp, and adipose CFU-F (,20 PDs) [41, 46, 47], which have similar capacity to that of small endometrial stromal CFU (13 PDs), and less than that of human fetal muscle cells (40…”
BackgroundHoming and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?
Becker, A. D., & Riet, I. V. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i3.73 · Cited by 460
Frenette, P. S., Pinho, S., Lucas, D., & Scheiermann, C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095919 · Cited by 462
Guillot, P. V., Gotherstrom, C., Chan, J., Kurata, H., & Fisk, N. M. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0208 · Cited by 460
Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review
Berebichez-Fridman, R., & Montero-Olvera, P. R. (2018) · Sultan Qaboos University Medical Journal · doi:10.18295/squmj.2018.18.03.002 · Cited by 450
Park, Y.-B., Ha, C.-W., Lee, C.-H., Yoon, Y. C., & Park, Y.-G. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0157 · Cited by 446
Mazini, L., Rochette, L., Amine, M., & Malka, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102523 · Cited by 445
“In adult patients and children with steroid-resistant acute GVHD, the infusion of allogeneic BM-MSCs resulted in the complete response and overall survival in most patients after UCB and HSCs transplantation without any side-effects during or immediately after MSCs infusion [167,168], while better outcomes were also o…”
BackgroundResultInfluentialMelief, S. M., Zwaginga, J. J., Fibbe, W. E., & Roelofs, H. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0184 · Cited by 442
The Potential of Adipose Stem Cells in Regenerative Medicine
Lindroos, B., Suuronen, R., & Miettinen, S. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9193-7 · Cited by 441
“MHC II +/± [73, 75, 98, 147, 220], * ± [98, 99, 147], * ± [98, 99]”
Adipose Tissue–Derived Human Mesenchymal Stem Cells Mediated Prodrug Cancer Gene Therapy
Kucerova, L., Altanerova, V., Matuskova, M., Tyciakova, S., & Altaner, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4024 · Cited by 431
Hu, L., Yin, C., Zhao, F., Ali, A., Ma, J., & Qian, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020360 · Cited by 431
“Recently, AD-MSCs have become one popular cell source of MSCs due to their easy isolation, greater abundance, and high production [130].”
BackgroundMesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices
Sharma, R. R., Pollock, K., Hubel, A., & McKenna, D. (2014) · Transfusion · doi:10.1111/trf.12421 · Cited by 430
“Bone/cartilage disorders Bone cysts 1 [6] 1 [10] Bone neoplasms 1 [50] Cartilage defect 1 [50] 2 [38] 1 [100] Degenerative osteoarthritis 2 [30] 1 [25] Distraction osteogenesis 1 [6] Fractures 2 [16] 1 [24] 1 [40] Ligament injury 1 [24] 1 [10] Meniscectomy 2 [110] Osteoarthritis 5 [42] 2 [45] 4 [222] 1 [104] Osteodysp…”
Rebelatto, C. K., Aguiar, A. M., Moretão, M. P., Senegaglia, A. C., Hansen, P., Barchiki, F., Oliveira, J., Martins, J., Kuligovski, C., Mansur, F., et al. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-rm-356 · Cited by 429
Mesenchymal Stem Cells Migration Homing and Tracking
Sohni, A., & Verfaillie, C. M. (2013) · Stem Cells International · doi:10.1155/2013/130763 · Cited by 424
“[8] S.”
BackgroundLee, E. Y., Xia, Y., Kim, W., Kim, M. H., Kim, T. H., Kim, K. J., Park, B., & Sung, J. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00499.x · Cited by 423
Stromal cells and stem cells in clinical bone regeneration
Grayson, W. L., Bunnell, B. A., Martin, E., Frazier, T., Hung, B. P., & Gimble, J. M. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.234 · Cited by 423
Kocaoemer, A., Kern, S., Klüter, H., & Bieback, K. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0627 · Cited by 414
Self-citationDual origin of mesenchymal stem cells contributing to organ growth and repair
Feng, J., Mantesso, A., De Bari, C., Nishiyama, A., & Sharpe, P. T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015449108 · Cited by 410
Jeong, J.-O., Han, J. W., Kim, J.-M., Cho, H.-J., Park, C., Lee, N., Kim, D.-W., & Yoon, Y.-S. (2011) · Circulation Research · doi:10.1161/circresaha.110.239848 · Cited by 410
Gandia, C., Armiñan, A., García-Verdugo, J. M., Lledó, E., Ruiz, A., Miñana, M. D., Sanchez-Torrijos, J., Payá, R., Mirabet, V., Carbonell-Uberos, F., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0484 · Cited by 406
Multipotent Stem Cells from Umbilical Cord: Cord Is Richer than Blood!
Secco, M., Zucconi, E., Vieira, N. M., Fogaça, L. L. Q., Cerqueira, A., Carvalho, M. D. F., Jazedje, T., Okamoto, O. K., Muotri, A. R., & Zatz, M. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0381 · Cited by 398
Adult Cardiac-Resident MSC-like Stem Cells with a Proepicardial Origin
Chong, J. J. H., Chandrakanthan, V., Xaymardan, M., Asli, N. S., Li, J., Ahmed, I., Heffernan, C., Menon, M. K., Scarlett, C. J., Rashidianfar, A., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.10.002 · Cited by 389
“Furthermore, MSCs isolated from different locations show biases with respect to lineage differentiation, suggesting organ-specific functions (Kern et al., 2006).”
Nie, C., Yang, D., Xu, J., Si, Z., Jin, X., & Zhang, J. (2011) · Cell Transplantation · doi:10.3727/096368910x520065 · Cited by 384
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review
Mastrolia, I., Foppiani, E. M., Murgia, A., Candini, O., Samarelli, A. V., Grisendi, G., Veronesi, E., Horwitz, E. M., & Dominici, M. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0044 · Cited by 350
Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells
Tolar, J., Le Blanc, K., Keating, A., & Blazar, B. R. (2010) · Stem Cells · doi:10.1002/stem.459 · Cited by 376
Al-Nbaheen, M., vishnubalaji, R., Ali, D., Bouslimi, A., Al-Jassir, F., Megges, M., Prigione, A., Adjaye, J., Kassem, M., & Aldahmash, A. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9365-8 · Cited by 361
Stem cells in dentistry – Part I: Stem cell sources
Egusa, H., Sonoyama, W., Nishimura, M., Atsuta, I., & Akiyama, K. (2012) · Journal of Prosthodontic Research · doi:10.1016/j.jpor.2012.06.001 · Cited by 374
“Although the intrinsic characteristics of ASCs appear to be different from those of BMSCs [26,130–132], ASCs exhibit robust osteogenesis and are thus expected to be an alternative source of MSCs for bone regeneration in dentistry.”
BackgroundKidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., Andreeff, M., & Marini, F. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030563 · Cited by 371
Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Cartilage, and Adipose Tissue
Peng, L., Jia, Z., Yin, X., Zhang, X., Liu, Y., Chen, P., Ma, K., & Zhou, C. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0217 · Cited by 368
“These results are similar to those of previous reports [18,19].”
A novel route in bone tissue engineering: Magnetic biomimetic scaffolds
Bock, N., Riminucci, A., Dionigi, C., Russo, A., Tampieri, A., Landi, E., Goranov, V. A., Marcacci, M., & Dediu, V. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2009.09.017 · Cited by 368
Role of adipose‐derived stem cells in wound healing
Hassan, W. U., Greiser, U., & Wang, W. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12173 · Cited by 365
Adipose-derived stem cells enhance peripheral nerve regeneration
di Summa, P. G., Kingham, P. J., Raffoul, W., Wiberg, M., Terenghi, G., & Kalbermatten, D. F. (2010) · Journal of Plastic, Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2009.09.012 · Cited by 359
Zhang, W., Bai, X., Zhao, B., Li, Y., Zhang, Y., Li, Z., Wang, X., Luo, L., Han, F., Zhang, J., et al. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.06.035 · Cited by 361
Tomar, G. B., Srivastava, R. K., Gupta, N., Barhanpurkar, A. P., Pote, S. T., Jhaveri, H. M., Mishra, G. C., & Wani, M. R. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.126 · Cited by 357
Gentile, P., & Garcovich, S. (2019) · Cells · doi:10.3390/cells8050466 · Cited by 333
Long-term In vitro Expansion Alters the Biology of Adult Mesenchymal Stem Cells
Izadpanah, R., Kaushal, D., Kriedt, C., Tsien, F., Patel, B., Dufour, J., & Bunnell, B. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5272 · Cited by 352
Mizuno, H. (2009) · Journal of Nippon Medical School · doi:10.1272/jnms.76.56 · Cited by 349
Aurich, H., Sgodda, M., Kaltwaßer, P., Vetter, M., Weise, A., Liehr, T., Brulport, M., Hengstler, J. G., Dollinger, M. M., Fleig, W. E., et al. (2009) · Gut · doi:10.1136/gut.2008.154880 · Cited by 346
Noël, D., Caton, D., Roche, S., Bony, C., Lehmann, S., Casteilla, L., Jorgensen, C., & Cousin, B. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.12.022 · Cited by 343
Procedure, applications, and outcomes of autologous fat grafting
Simonacci, F., Bertozzi, N., Grieco, M. P., Grignaffini, E., & Raposio, E. (2017) · Annals of Medicine & Surgery · doi:10.1016/j.amsu.2017.06.059 · Cited by 343
Tissue Engineered Bone Grafts: Biological Requirements, Tissue Culture and Clinical Relevance
Frohlich, M., Grayson, W., Wan, L., Marolt, D., Drobnic, M., & Vunjak- Novakovic, G. (2008) · Current Stem Cell Research & Therapy · doi:10.2174/157488808786733962 · Cited by 342
“While expression of CD34 is negative for BMSC, there are different reports for ADSC [29, 31, 35].”
BackgroundHuman Bone Marrow and Adipose Tissue Mesenchymal Stem Cells: A User's Guide
Mosna, F., Sensebé, L., & Krampera, M. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0140 · Cited by 330
“MSCs have been isolated from almost every tissue of the body [4,5], including lymphoid organs (thymus and spleen) [21], subcutaneous fat [22,23], periodontal ligament [24], scalp tissue [25], endometrium and menstrual blood [26], peripheral blood [6], umbilical cord blood [27] and Wharton’s jelly [28,29], as well as f…”
Markers Distinguishing Mesenchymal Stem Cells from Fibroblasts Are Downregulated with Passaging
Halfon, S., Abramov, N., Grinblat, B., & Ginis, I. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0040 · Cited by 326
“In another study comparing BM and adipose tissue-derived MSCs, expression of all tested markers was similar in both cell types except CD106, which was significantly lower in adipose MSCs [69].”
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis
Riordan, N. H., Ichim, T. E., Min, W.-P., Wang, H., Solano, F., Lara, F., Alfaro, M., Rodriguez, J. P., Harman, R. J., Patel, A. N., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-29 · Cited by 324
Docheva, D., Popov, C., Mutschler, W., & Schieker, M. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00001.x · Cited by 324
“[16] and presented a juxtaposing of MSCs isolated from three sources and expanded under identical culture conditions.”
BackgroundMesenchymal stem cells engineered for cancer therapy
Shah, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.010 · Cited by 322
“Umbilical cord blood derived MSC expand at a higher rate as compared to bone marrow and adipose-derived MSCs [13, 19], which may be due in part to higher telomerase activity[20].”
BackgroundResultInfluentialTechnology Insight: adult stem cells in cartilage regeneration and tissue engineering
Chen, F. H., Rousche, K. T., & Tuan, R. S. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0216 · Cited by 319
Hsieh, J.-Y., Wang, H.-W., Chang, S.-J., Liao, K.-H., Lee, I.-H., Lin, W.-S., Wu, C.-H., Lin, W.-Y., & Cheng, S.-M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072604 · Cited by 318
Costa, L. A., Eiro, N., Fraile, M., Gonzalez, L. O., Saá, J., Garcia-Portabella, P., Vega, B., Schneider, J., & Vizoso, F. J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03600-0 · Cited by 313
Cell-scaffold interactions in the bone tissue engineering triad
Orthopaedic Research and Biotechnology, R. B., Murphy, C., O’Brien, F., Little, D., & Schindeler, A. (2013) · European Cells and Materials · doi:10.22203/ecm.v026a09 · Cited by 312
“Similar to bone marrow and adipose tissue, umbilical cord blood has a population of multipotent MSCs that can be differentiated down an osteogenic lineage (Kern et al., 2006).”
BackgroundStem Cells and Cell Therapies in Lung Biology and Lung Diseases
Weiss, D. J., Kolls, J. K., Ortiz, L. A., Panoskaltsis-Mortari, A., & Prockop, D. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200804-037dw · Cited by 309
The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity
Zhou, Y., Yamamoto, Y., Xiao, Z., & Ochiya, T. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071025 · Cited by 303
“MSCs isolated from fetal tissues such as umbilical cord (UC) and UC-blood (UCB) were shown to have increased secretion of proinflammatory proteins and growth factors than MSCs obtained from adult adipose tissue or bone marrow [17,18].”
BackgroundMesenchymal Stromal Cells: Facilitators of Successful Transplantation?
English, K., French, A., & Wood, K. J. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.09.009 · Cited by 303
“Since then, MSCs have been isolated from a number of other sources, including umbilical cord blood, adipose tissue, muscle, and liver (da Silva Meirelles et al., 2006; Kern et al., 2006).”
BackgroundLI, X., BAI, J., JI, X., LI, R., XUAN, Y., & WANG, Y. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1821 · Cited by 301
“MSCs derived from different tissues have been demonstrated in a large number of studies to differentiate into cells in the mesodermal lineages, such as osteoblasts and adipocytes (41-44).”
BackgroundMattar, P., & Bieback, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00560 · Cited by 300
Self-citationComparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy
Ikegame, Y., Yamashita, K., Hayashi, S.-I., Mizuno, H., Tawada, M., You, F., Yamada, K., Tanaka, Y., Egashira, Y., Nakashima, S., et al. (2011) · Cytotherapy · doi:10.3109/14653249.2010.549122 · Cited by 293
Nakamura, S., Yamada, Y., Katagiri, W., Sugito, T., Ito, K., & Ueda, M. (2009) · Journal of Endodontics · doi:10.1016/j.joen.2009.07.024 · Cited by 298
Freitag, J., Bates, D., Boyd, R., Shah, K., Barnard, A., Huguenin, L., & Tenen, A. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1085-9 · Cited by 281
“In comparison, human adipose tissue through a lipoaspirate procedure, yields MSC numbers of ~ 1–7 % of the nucleated cell population [74].”
BackgroundStrategies for Bone Regeneration: From Graft to Tissue Engineering
Battafarano, G., Rossi, M., De Martino, V., Marampon, F., Borro, L., Secinaro, A., & Del Fattore, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031128 · Cited by 295
The wound-healing and antioxidant effects of adipose-derived stem cells
Kim, W.-S., Park, B.-S., & Sung, J.-H. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903039684 · Cited by 294
“Given their convenient isolation compared with BMSCs and extensive proliferative capacities ex vivo, ADSCs hold great promise for use in wound repair and regeneration [24,46].”
BackgroundBone marrow and umbilical cord blood human mesenchymal stem cells: state of the art.
Malgieri, A., Kantzari, E., Patrizi, M. P., & Gambardella, S. (2010) · PubMed Central · Cited by 349
Papaccio, F., Paino, F., Regad, T., Papaccio, G., Desiderio, V., & Tirino, V. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0138 · Cited by 292
Natural history of mesenchymal stem cells, from vessel walls to culture vessels
Murray, I. R., West, C. C., Hardy, W. R., James, A. W., Park, T. S., Nguyen, A., Tawonsawatruk, T., Lazzari, L., Soo, C., & Péault, B. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1462-6 · Cited by 291
“CD90 Thy-1 [27, 35, 148, 256, 258, 259, 262, 263] [27, 106, 260, 263–265, 295] [13, 15–17]”
BackgroundInfluentialWang, Z.-G., He, Z.-Y., Liang, S., Yang, Q., Cheng, P., & Chen, A.-M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02032-8 · Cited by 288
An Update on Adipose‐Derived Stem Cells for Regenerative Medicine: Where Challenge Meets Opportunity
Qin, Y., Ge, G., Yang, P., Wang, L., Qiao, Y., Pan, G., Yang, H., Bai, J., Cui, W., & Geng, D. (2023) · Advanced Science · doi:10.1002/advs.202207334 · Cited by 260
Mesenchymal stem cells: Amazing remedies for bone and cartilage defects
Kangari, P., Talaei-Khozani, T., Razeghian-Jahromi, I., & Razmkhah, M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02001-1 · Cited by 286
Strategies to engineer tendon/ligament-to-bone interface: Biomaterials, cells and growth factors
Font Tellado, S., Balmayor, E. R., & Van Griensven, M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.004 · Cited by 286
Roubelakis, M. G., Pappa, K. I., Bitsika, V., Zagoura, D., Vlahou, A., Papadaki, H. A., Antsaklis, A., & Anagnou, N. P. (2007) · Stem Cells and Development · doi:10.1089/scd.2007.0036 · Cited by 283
“In addition, the number, the proliferation, and the differentiation potential of these cells decline with increasing age (10).”
Najar, M., Raicevic, G., Boufker, H. I., Kazan, H. F., Bruyn, C. D., Meuleman, N., Bron, D., Toungouz, M., & Lagneaux, L. (2010) · Cellular Immunology · doi:10.1016/j.cellimm.2010.06.006 · Cited by 275
“Among these tissues, adipose tissue (AT) [5] and Wharton’s jelly (WJ) of the umbilical cord [6] have been considered as potential alternatives to BM.”
BackgroundKunter, U., Rong, S., Boor, P., Eitner, F., Müller-Newen, G., Djuric, Z., van Roeyen, C. R., Konieczny, A., Ostendorf, T., Villa, L., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010044 · Cited by 275
Chen, M.-Y., Lie, P.-C., Li, Z.-L., & Wei, X. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.02.003 · Cited by 270
“2 mM L-ascorbate, and 10 mM b-glycerophosphate (Sigma-Aldrich, St Louis, MO, USA) [24,25].”
BackgroundMethodInfluentialStem and progenitor cell-mediated tumor selective gene therapy
Aboody, K. S., Najbauer, J., & Danks, M. K. (2008) · Gene Therapy · doi:10.1038/gt.2008.41 · Cited by 270
Metadata
- Authors
- Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K.
- Affiliations
- German Red Cross (DE)
- Department of Orthopaedic Surgery of the University Hospital Mannheim, University of Heidelberg, Faculty of Clinical Medicine, Mannheim, Germany
- Corresponding author
- Bieback, Karen
- Venue
- STEM CELLS
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05
- Volume
- 24
- Issue
- 5
- Pages
- 1294-1301
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2036348189
- Cited by
- 3,370
- References
- 37
- Citations by year
- 2026: 57 · 2025: 97 · 2024: 142 · 2023: 136 · 2022: 176 · 2021: 201 · 2020: 225 · 2019: 197 · 2018: 190 · 2017: 193 · 2016: 208 · 2015: 218 · 2014: 225 · 2013: 242 · 2012: 213
- FWCI
- 49.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, bone marrow, umbilical cord blood, adipose tissue, stem cell isolation, adipogenesis, multilineage differentiation, immunophenotype, stem cell expansion, cell therapy
- MeSH terms
- Adipose Tissue, Aged, Aged, 80 and over, Antigens, Surface, Bone Marrow Cells, Cell Differentiation, Cells, Cultured, Fetal Blood, Humans, Osteogenesis, Immunophenotyping, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.